Nottingham-based contract research organisation (CRO) Cellomatics Biosciences has today been recognised with one of the UK’s most prestigious business awards – the Queen’s Award for Enterprise for International Trade.
Cellomatics is one of 225 organisations nationally to be recognised with a prestigious Queen’s Award for Enterprise.
Employing 15 people, Cellomatics was founded in 2015 and specialises in the development of bespoke bioassays across numerous therapeutic areas including oncology, immuno-oncology, immunology, inflammation and respiratory.
Last year, the company reported year-on-year organic growth of 30 percent since it was founded, in the wake of increased demand for its bespoke preclinical and early discovery phase laboratory services and expertise.
The company’s exported business has increased over 15-fold, with export sales now representing approximately 50 percent of total revenue. Significant growth has come from clients based in Europe, Asia and the USA.
Cellomatics’ CEO and founder, Dr Shailendra Singh, said: “It is an absolute honour to be recognised with the prestigious Queen’s Award for Enterprise and for our excellence in international trade, particularly on the year of the Queen’s Platinum Jubilee.
“Cellomatics has continuously moved from strength to strength since our inception over six years ago. We’re proud to have successfully completed over 200 projects in collaboration with approximately 70 clients in the last six years, with between 10 and 15 new clients secured each year, and around half of our clients placing repeat business. This has translated into strong revenue growth from an expanding international and diversified customer base.
“None of this would be possible without the dedication of our skilled team of scientists and our shared focus, vision, and ambition to constantly improve and deliver quality results for our growing network of clients. We’re also proud to be located at the heart of the UK in the East Midlands which is a hub for thriving life sciences businesses and CROs driving innovation on an international and global scale.”
Now in its 56th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the country, with winning businesses able to use the esteemed Queen’s Awards Emblem for the next five years.
Cellomatics was recently crowned regional winner in the Barclays Entrepreneur Awards 2021 and its CEO Shailendra Singh was awarded Small Business Entrepreneur of the Year for the Midlands at the Great British Entrepreneur Awards.
Issued for and on behalf of Cellomatics Biosciences by V Formation Ltd. For more information, contact:
Sue Carr: [email protected] / 07809 727533
